Clinical Trials for Hidradenitis Suppurativa

Why clinical trials matter for HS

For many years, people with hidradenitis suppurativa had few treatments that were formally tested and approved for the condition. Clinical trials changed that. Carefully designed studies are how a promising idea becomes evidence — and how that evidence eventually becomes a treatment a doctor can prescribe.

Trials also protect patients. They measure not only whether a treatment helps, but how often side effects occur, so benefits and risks can be weighed honestly. Some trials show that a treatment does not work well enough, which is just as important to know.

How to use the Trial Finder

The Trial Finder searches the public ClinicalTrials.gov registry for HS studies with locations in Germany. Enter a German postal code, choose how far you could travel, and optionally add your age or the type of research you want to see.

The finder shows only studies with at least one German location that is recruiting now or expected to open. It checks each individual site — not just the study's overall status — because a large international trial can be labelled ‘recruiting’ even when its German site is already closed.

• Recruiting now: at least one nearby location is registered as recruiting.
• Expected to open: a nearby location is registered as not yet recruiting and may not accept enquiries yet.
• Results are sorted by status and distance, never by ‘best’ or ‘most suitable’.

What a search result does and does not mean

Appearing in the results means a study matches your search settings — a condition, a status and a nearby location. It does not mean you are eligible, and it does not mean the treatment would help you.

Eligibility depends on detailed criteria that only a study team can apply, using your full medical history. The finder never tells you that you qualify. Use it to find studies worth asking about, then talk to the study team and your own doctor.

Scientific research, editorial review, and sources

The articles in this hub separate trial results from regulatory approval, and approved medicines from investigational treatments. Facts about specific trials and approvals are drawn from ClinicalTrials.gov, the European Medicines Agency, the U.S. Food and Drug Administration, peer-reviewed publications and recognised patient-research organisations (EUPATI, CISCRP). Live study data comes directly from ClinicalTrials.gov at the moment you search.

Editorial review: July 2026. This hub is written and reviewed by Dr. Dennis Kwiatkowski (biochemist). It is educational and does not replace advice from qualified healthcare professionals or a study team.